Developing a molecule, to aim to treat Breast and Pancreatic Cancer.

Summary

Transcriptogen Ltd is developing a cancer treatment.  The Company has developed a molecule, TSG1301, which is intended to treat Breast and Pancreatic Cancer tumours.

Product

Life Sciences SEIS

Sector

Cancer treatment

Status

Closed

HMRC

Advanced Assurance